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Abstract. Targeting of P-selectin to the regulated 
secretory organelles (RSOs) of phaeochromocytoma 
PC12 cells has been investigated. By expressing from 
cDNA a chimera composed of HRP and P-selectin, and 
then following HRP activity through subcellular frac- 
tionation, we have discovered that P-selectin contains 
signals that target HRP to the synaptic-like microvesi- 
cles (SLMV) as well as the dense-core granules 
(DCGs) of these cells. Mutagenesis of the chimera fol- 
lowed by transient expression in PC12 cells shows that 
at least two different sequences within the carboxy-ter- 
minal cytoplasmic tail of P-selectin are necessary, but 
that neither is sufficient for trafficking to the SLMV. 
One of these sequences is centred on the 10 amino ac- 
ids of the membrane-proximal C1 exon that is also im- 
plicated in lysosomal targeting. The other sequence 
needed for trafficking to the SLMV includes the last 
four amino acids of the protein. The same series of mu- 
tations have a different effect on DCG targeting, show- 
ing that traffic to the two different RSOs depends on 
different features within the cytoplasmic domain of 
P-selectin. 
N 
'EUROENDOCRINE cells  possess  two  kinds  of  or- 
ganelles for regulated exocytosis; small synaptic 
or  synaptic-like  microvesicles  (SLMVs)  1  and 
dense-core secretory granules  (DCGs).  The former con- 
tain only small molecules, the latter contain peptides and 
proteins as well. The ratio of these two regulated secretory 
organelles (RSOs)  varies with cell type (35).  Some pro- 
teins are found in the membranes of both organelles, reflect- 
ing the common requirements of exocytotic machinery (5, 
36).  This raises  the  question of how such a  biorganellar 
distribution is attained. The itinerary of such proteins must 
be complex, since the biogenesis of DCGs in the TGN is 
very different from SLMV formation, which probably oc- 
curs in some part of the endosomal system. Moreover, the 
relationship  between proteins that  become incorporated 
into the two different RSOs is unclear; for example, we do 
not know whether membrane proteins move from one or- 
ganelle to the other via recycling, nor at what point the 
traffic bifurcates. In addition, very little is known at the 
present time about the signals involved in RSO targeting 
of membrane proteins. 
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1. Abbreviations used in this paper: BB, blotting buffer; DCG, dense-core 
granule; HB, homogenization buffer; PAM, peptidyl-amidating monooxy- 
genase;  RSO,  regulated  secretory  organelle;  SLMV,  synaptic-like  mi- 
crovesicle; TfnR, transferrin receptor. 
Biogenesis of the  SLMVs,  and  by implication that  of 
small synaptic vesicles in neurons, is poorly understood. 
Most evidence suggests a  central role for an endosomal 
compartment in SLMV origins. First, expression in non- 
neuronal cells usually leads to localization in endosomal 
compartments, often but not always those enriched in the 
transferrin receptor (4, 14, 25, 28, 29). The most parsimo- 
nious explanation for this is that the machinery necessary 
for a single sorting step is missing, thereby losing transfer 
from the endosome to the SLMV. Second, overlapping lo- 
calization of endosomal markers such as tab5 (10, 15) and 
the transferrin receptor (TfnR; 4, 34) with SLMV mem- 
brane proteins suggests that cycling through the endosome 
is part of the itinerary followed by SLMV proteins. Third, 
considerable evidence has arisen from a detailed analysis 
of the trafficking of synaptophysin in PC12 cells. These rat 
phaeochromocytoma cells possess both RSOs (17, 18), are 
easily transfectable, and have become a major system for 
investigations into RSO biogenesis, since there are well- 
characterized subcellular fractionation procedures for the 
isolation of both granules (8, 9, 41) and vesicles (6, 8, 20, 
37). Studies of SLMV biogenesis in PC12 cells have led to 
the conclusion that the integral membrane protein synap- 
tophysin (or p38; 3, 22, 43, 45), found almost exclusively 
within SLMVs in PC12 cells (9), traffics from the trans- 
Golgi to the cell surface, and is then internalized and recy- 
cled through endosomal elements before being sorted into 
the SLMV (1, 9, 27, 37). 
This itinerary has clear implications for the targeting sig- 
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protein. 
Mutagenesis of endosomal marker proteins such as the 
TfnR has revealed that to attain an efficient recycling itin- 
erary, a short cytoplasmic signal mediating recruitment to 
the coated pit is required (44). Removal of the cytoplasmic 
domain  of  synaptophysin  causes  accumulation  on  the 
plasma  membrane  when  the  truncated  protein  is  ex- 
pressed in nonneuroendocrine cells (29). In addition, it is 
becoming  apparent  that  escape  from  the  endosome- 
plasma membrane recycling itinerary to other destinations 
is  a  signal-mediated  step  (38).  Together, these  observa- 
tions suggest that synaptophysin will require both a clath- 
rin-coated pit internalization signal and a second sequence 
for subsequent sorting from the endosome to the SLMV to 
achieve the observed itinerary (see Fig. 10 A). However, 
this hypothesis has yet to be tested. In contrast, in the case 
of the integral membrane protein VAMP II (synaptobre- 
vin II; 13), which is found in both SLMVs and DCGs in 
PC12  ceils  (5,  36),  a  single  amphipathic  helix has  been 
demonstrated  to  be  involved  in  SLMV  targeting  (20). 
Moreover, finding  mutants  that  increase  as  well  as  de- 
crease targeting has led to the hypothesis that VAMP II is 
targeted by interaction with another protein (20). Clearly, 
the situation is both complex and unclear. 
Targeting of membrane proteins to DCGs is also poorly 
understood. Two proteins, peptidyl-amidating monooxy- 
genase (PAM) and P-selectin, have been studied in some 
detail. PAM is a type 1 membrane protein that is found in 
several forms, including a soluble variant. Experiments in 
AtT-20 cells have shown that the granule targeting infor- 
mation is in the luminal portion of the molecule (31), but 
additional information affecting the efficiency of targeting 
is found in the cytoplasmic domain (33). In addition, PAM 
is internalized to perinuclear endosomes after reaching the 
cell surface, in a process that is dependent on the cytoplas- 
mic tail of the molecule (32). 
P-selectin is a type 1 membrane protein found in endo- 
thelial granules and platelets, and is  involved in binding 
monocytes and neutrophils following its regulated appear- 
ance on the cell surface as part of the inflammatory re- 
sponse (24, 30). Expression in the pituicyte line AtT-20 re- 
vealed that it was targeted to the secretory granules and 
studies using chimeras revealed that the cytoplasmic do- 
main was both necessary and sufficient for this targeting 
(12, 26). Following the fate of P-selectin by antibody-feed- 
ing experiments on transfected AtT-20 cells stimulated to 
secrete suggested that recycling of P-selectin to the gran- 
ules in these cells can occur (42). This trafficking was de- 
pendent on sequences present in the C1 and C2 exons of 
the cytoplasmic domain (see Fig. 1). More recently, exper- 
iments in CHO cells have suggested the presence of a lyso- 
somal targeting signal in the membrane-proximal C1  do- 
main of the cytoplasmic domain (16). P-selectin therefore 
contains  signals  providing for a  complex endocytic traf- 
ficking as well as for DCG targeting. 
The current state of knowledge as sketched above sug- 
gests that the signals for targeting to the two RSOs found 
within  a  membrane  protein  present  in  both  DCGs  and 
SLMVs will be different. Before this work, this hypothesis 
has not been tested. We have made a series of chimeras 
between P-selectin and the enzymatically active reporter 
HRP  (ssHRP  Pselectin) to  examine  targeting  to  RSOs  in 
PC12  cells. The chimeras have  been expressed in  PC12 
cells, and we have found that in addition to granule target- 
ing, ssHRP  P-selectin is also found in the SLMVs. We have 
found that two separate regions of the cytoplasmic tail are 
involved in SLMV targeting, and that the sequences for 
DCG targeting differ from those involved in targeting to 
the SLMV. 
Materials and Methods 
Cell Culture and Transfection 
PC12 cells grown as described (8) were transiently transfected by elec- 
troporation  (7).  1 d  before transfection, the cells were plated to ~75% 
confluency.  On  the  day  of  transfection,  a  9-cm dish  was  trypsinized, 
washed once  in  DME plus sera,  then twice  in  ice-cold  Hebs (20 mM 
Hepes, pH 7.05, 137 mM NaC1, 5 mM KCI, 0.7 mM Na2HPO4, and 6 mM 
glucose). The cells were finally resuspended in 250 p,l of Hebs in a 0.4-cm 
cuvette. 10-20 I~l (~10 ~g) of DNA was added, and the DNA/cell mix was 
given two pulses in a gene pulser (400 V, 125 I~F, and infinite l~; Bio Rad 
Laboratories, Hercules, CA). After 5 min, the cells were reseeded into a 
9-cm dish in DME plus sera. 
Constructs 
ssHRP  e'seuain in pRK34.  We assembled a  chimeric eDNA containing the 
human growth hormone signal sequence, followed by HRP and finally the 
transmembrane domain and cytoplasmic tail of P-selectin (Fig. 1). eDNA 
clones corresponding to the transmembrane domain and cytoplasmic tail 
of P-selectin were obtained using mRNA purified from human umbilical 
vein endothelial  cells (using a  kit  from BIO  101,  Inc., San Jose,  CA). 
PolyA  + RNA, purified using oligo(dT)25  dynabeads (Dynal, Oslo, Nor- 
way), was then transcribed into eDNA using reverse transcriptase accord- 
ing to the manufacturer's instructions (Promega Biotech, Madison, WI). 
The P-selectin sequences required were then amplified from the eDNA 
using the following primers: 5'-GAGAACTGCAGAGTGGTCAACAG- 
CAACTCTA TCCAGGAAGCCCTGACT-3' (sense) and 5'GAGAGG- 
ATCCGTGTYI'ATGG AAACCTFAAG-3' (antisense). This PCR product 
was cut with BamH1 and Pstl, and ligated into an HRP-pUC19 construct, 
where the HRP eDNA (British Biotech. Ltd., Oxford, UK) was cloned be- 
tween the HindIII and EcoR1 sites in the polylinker of pUC19 that had 
been cut with the same two enzymes. Altogether, this generated an HRP- 
P-selectin fusion. 
This fusion was digested with Sall/BamH1 to give a  765-bp fragment 
containing the last half of HRP and the P-selectin transmembrane domain 
and  cytoplasmic tail.  This was  ligated  into  pRK34  containing ssHRP 
KDEL (7), which had been previously digested with Sall/Bglll, thus creat- 
ing ssHRP  P-selectin.  pRK34 was made from pGW1 (2) by taking the EcoR1/ 
HindIII-ended polylinker from pSL1180 (Pharmacia Biotech, Piscataway, 
N J) and inserting it into the EcoR1/HindIII site of pGW1. ssHRP KDEL 
was moved into pRK34 from pSRc~ (7) as a BamH1 fragment. 
ssHRP P-Selectin Deletion Mutants.  Deletion  mutants were  produced 
by PCR using a  primer internal to HRP and primers to the cytoplasmic 
tail such that a STOP codon followed by an Nsil site was inserted at the re- 
quired positions. These PCR products were cut with Bglll and Nsil and li- 
gated into pRK34.ssHRP  P-~electin, which had been previously cut with Bglll 
and Pstl. 
Internal primer." GGCCAACGCCAACTTGCC 
Cytoplasmic  tail primers: 
P-selectin 786: GAAGAAATGCAqTI'AAAATGCAGCGq~I'TGT 
P-selectin 776: GAAGAAATGCATTTATGTAAAAACTCCATA 
P-selectin  782:  GAAGAAATGCATYI'ATCCTAGGTGGCTGTGAG- 
GATTCAA 
P-selectin 763: GAAGAAATGCATTI'AGGCTFCCTGGATAGTCAA- 
TGGTCC 
ssHRP P-Selectin  ACI.  Primers were designed to leave a  Bell site on 
the 3'  end  of the ST region of the P-selectin tail  (CCCAAGATCTr- 
qq'TGTCTG) and a Bglll site on the 5' of the C2 region (CCTCATGAT- 
CACCTAGGAAC). These were ligated together and then ligated into 
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by sequencing. 
Fractionation and Analysis 
FicoUGradientFractionation. The  procedure  used  was  the  system  de- 
scribed by Cramer and Cutler (8). PC12 cells were grown for 1-4 d after 
transfection, and DCG were labeled by incubating the cells for 2 h with 0.5 
p~Ci/ml  3H-dopamine  (Amersham  International,  Amersham,  UK)  in 
DMEM. All operations were carried out at 4°C. Cells were washed once 
with 0.32 M sucrose, 10 mM Hepes, pH 7.4 (HB), scraped into 1 ml HB, 
and homogenized by nine passages through a  ball-bearing homogenizer 
with  a  0.012-mm  clearance  (made  in  the  EMBL  workshop,  EMBL, 
Heidelberg, Germany). The cell  homogenate was spun at 11,000 g for 5 
min, and 1 ml of the supernatant (PNS) was layered on 11 ml of a 1-16% 
Ficoll linear gradient made in HB. The gradients were centrifuged for 45 
min at 35,000 rpm in a SW40Ti  rotor (Beckman Instruments, Palo Alto, 
CA) and fractionated in 0.5-ml fractions from the top of the tube using an 
Autodensi-Flow I1C (Buchler Instruments, Kansas City, MO). 
Sucrose Gradient DCG Isolation.  Purification of DCGs by pooling frac- 
tions containing the 3H-dopamine peak from a Ficoll gradient and centri- 
fuging to equilibrium on a 0.5-2-M sucrose gradient was carried out 4 d af- 
ter transfection, as described (36). 
Sucrose Gradient SLMVIsolation.  Fractions 2 and 3 from a Ficoll  gra- 
dient prepared as described above were layered onto an ll-ml 0.4-1.2-M 
linear sucrose (in 10 mM Hepes, pH 7.4) gradient. This was spun to equi- 
librium in a Beckman SW40Ti rotor at 25,000 rpm for 17 h, and then 0.5- 
ml fractions were collected  and analyzed. 
Glycerol Gradient SLMVlsolation.  PC12  cells  were assayed 2  d  after 
transfection, since sufficient  enzyme activity  for easy determinations was 
present at this point. The procedure used was a modification of the one 
described by Kelly and co-workers (20). Briefly, the cells were rinsed with 
and then resuspended in 1 ml of buffer A (150 mM NaCl, 0.1 mM MgCl2, 
1 mM EGTA, and 10 mM Hepes, pH 7.4). They were then homogenized 
by nine passages through a  ball-bearing homogenizer with a  0.012-mm 
clearance (EMBL workshop). The homogenate was then centrifuged in a 
benchtop microfuge at 14,000 g for 15 min. 1 ml of the resulting superna- 
tant ($1) was loaded onto the top of an 11-ml 5-25% glycerol (in buffer 
A) gradient. This was centrifuged in a Beckman SW40 Ti rotor at 35 krpm 
for 2 h and 50 min. 0.5-ml fractions were then collected  from the top using 
an Autodensi-Flow IIC (Buchler Instruments). 
SDS-PA  GE and Immunoblotting 
Proteins were separated on 10%  SDS-polyacrylamide slab gels, and then 
transferred to nitrocellulose at 300 mA for 60 min. After incubation over- 
night with 5% BSA, 0.2%  Tween 20 in PBS  (blotting buffer; BB), nitro- 
cellulose  sheets were incubated with rabbit anti-p38  (made by immunizing 
with the carboxy-terminal cytoplasmic domain of rat brain p38 [3] as a glu- 
tathione S-transferase fusion protein; kind gift from R. Kelly,  University 
of  California,  San  Francisco,  CA  and  K.  Buckley,  Harvard  Medical 
School, Boston, MA) primary antibodies for i h, washed three times in 1 h 
with BB, and then incubated with HRP-conjugated anti-rabbit (Jackson 
ImmunoResearch  Laboratories, West Grove, CA) antibodies in BB for 1 h. 
After washing two times for 20 min with BB and once in just PBS,  anti- 
gens were detected by the ECL reaction (Amersham) and exposed to au- 
toradiographic films.  For quantitative  immunodetection, the signal  was 
measured with a GS-250 Molecular Imager (Bio Rad) after exposure to a 
chemiluminescence-sensitive screen for 5 rain. 
Immunoprecipitation 
6-cm dishes of PC12 cells to be immunoprecipitated were rinsed in DME 
lacking  methionine  (ICN-Flow, Oxfordshire,  UK),  and  were  then  re- 
placed in this medium supplemented with 0.25 mCi/dish of Tran35S-label 
(ICN-Flow) for 20  rain.  They were then removed from the  incubator, 
rinsed with ice-cold  PBS, and lysed on ice with 0.5 ml NDET (1% NP-40, 
0.6% deoxycholate, 66 mM EDTA, 10 mM Tris, pH 7.5) supplemented with 
PMSF  (1  mM).  Nuclei  and  debris  were  removed  by  centrifugation  at 
14,000 g. The supernatant was adjusted to 0.3%  SDS and fixed Staphylo- 
coccus aureus cells  were added  (60  I-d of a  10%  suspension, Pansorbin; 
Calbiochem, La Jolla,  CA). This suspension was rotated at 4°C for 45 min 
before removing the  Pansorbin by centrifugation. The supernatant was 
taken, 2 p.l rabbit anti-HRP (Dako) was added, and the sample was then 
incubated at 4°C overnight. Fresh Pansorbin (60 ~1) was then added, and 
the sample was incubated at 4°C for an additional 45 min. The pellet was 
then collected,  washed in 1 ml NDET/SDS, then 1 mt NDET/SDS/0.5 M 
NaCI, and finally  in  1 ml PBS,  and  then resuspended in 50 I~l sample 
buffer for SDS-PAGE. 
HRP Assay 
Fractions were assayed in triplicate.  50 Ixl of each fraction was added to 50 ~l 
of the assay reagent (100 mM citrate buffer, pH 5.5, 10%  Triton X-100, 
0.02%  H202,  and 0.1%  o-phenylene diamine [Sigma  Immunochemicals, 
St. Louis, MO]). This was then incubated in the dark at room temperature 
for 1 h. The reaction was stopped by adding 50 ixl of 2 M HCI, and the 
plates were read at 450 nm using a Bio Rad model 3550 microplate reader. 
Where appropriate, data obtained from glycerol  gradients was corrected 
(multiplied by 2.5) for its effect on enzyme activity,  as were data from Fi- 
coil gradients (multiplied by 1.2). 
Immunoadsorption 
lmmunoadsorption was carried out essentially as described (1t). M-450 
Dynabeads (Dynal, Oslo, Norway) coated with rat anti-mouse IgG1 were 
incubated with SVP-38 (monoclonal antisynaptophysin, IgG1; Sigma) or a 
control of mouse antimyeloperoxidase  (IgG1; Dako)  in  PBS  with  1% 
BSA for 16 h overnight at 4°C on a rotator, and then rinsed with PBS/BSA 
supplemented with 2% FCS. The beads were then mixed with pooled frac- 
tions containing the peak of HRP activity  taken from a glycerol gradient. 
Binding of membranes to the beads occurred over 90 rain at room temper- 
ature, the beads were then washed, extracted in PBS, supplemented with 
1% TritonX-100, and HRP activity was determined as described above. 
Antibody Feeding 
After transfection, cells  were plated  into dishes containing glass cover- 
slips. After 2 d, the medium was replaced with full growth medium supple- 
mented with 1.25 }xg/ml rabbit (Dako) or mouse (Sigma) anti-HRP. A 1-h 
incubation was followed by a brief rinse in PBS and indirect immunofluo- 
rescence was carried out using appropriate secondary antibodies (Jackson 
Laboratories) as described (8). Slides were viewed on an MRC-1000  con- 
focal microscope (Bio Rad Laboratories). 
Results 
We initially set out to analyze the granule-targeting signals 
present in P-selectin. The cytoplasmic tail of this protein 
has been shown to contain the information responsible for 
targeting to granules  (12),  and we therefore constructed 
ssHRP  Psel~ctin in which a reporter (HRP) replaces the lu- 
minal domain  of this  type 1 membrane protein  (Fig.  1). 
HRP was used as the reporter to provide for an extremely 
rapid, quantitative, and convenient assay for analyzing the 
distribution  of this  chimera  during  subcellular  fraction- 
ation. The ease of assay also makes feasible the processing 
of larger numbers of smaller fractions to increase the reso- 
lution of our analyses. 
ssHRP P'selectin was transiently expressed in PC12 cells by 
electroporation, which leads to ,-~30% of the cells express- 
ing the  chimera. In an  initial  experiment,  cells were  as- 
sayed for targeting of ssHRP P'selectin to DCGs at various 
times  after transfection  to determine  the  time course of 
HRP activity accumulation in the DCGs. The cells to be 
assayed were labeled with 3H-dopamine to mark the pres- 
ence of the DCGs during fractionation, homogenized, and 
a postnuclear supernatant centrifuged on a gradient con- 
sisting  of  1-16%  Ficoll  in  isoosmotic  sucrose.  Samples 
from the gradient were collected and assayed for peroxi- 
dase activity, as well as counted for 3H-dopamine (Fig. 2). 
The results show an accumulation with time of HRP activ- 
ity in  fractions  12-19,  which  correspond  to those  where 
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ssHRP  Pselectin  782 
ssHRP  Pselectin  776 
ssHRP  Pselectln ~cl 
ssHRP  Pselectin  763 
hGH  HRP  Pselectin 
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ssHRP  Pselectin  IM..GSAFPTIPLSI  SGTKLLEF  [QLTPT.....VNSNSIIQEA..DPSP  I 
/ 
TM  ST  C  l  C2 
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LL-'~RKRFRQKDDGKCPLNPHSHLGTYGVFTNAAF 
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LL-'~RKRF  RQKDD  GKCPLNPHSHLG 
LL-'~RKRFRQI(D  NLGTYGVFTNAAFDPSP 
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Figure 1.  P-selectin chimeras. This figure shows the overall lay- 
out and relevant sequences of the chimeras used in this paper. 
The top line shows the main components, boxes illustrating the 
extent  of the  individual components.  Sequences outside  boxes 
were added during construction, hGH, human growth hormone 
signal sequence; P-selectin, transmembrane  and cytoplasmic do- 
mains of P-selectin. The second line shows an expanded display 
of the transmembrane (TM) and cytoplasmic domains of P-selec- 
tin. The cytoplasmic tail includes the stop transfer (ST) and the 
C1 and C2 exons. The bottom part shows the full amino acid se- 
quences of the cytoplasmic domains of the chimeras starting with 
the wild-type P-selectin tail, ssHRP P-selectin. The carboxy-terminal 
end of the TM domain shown is boxed. The figure at the end of 
the mutant name indicates which amino acid has been changed to 
the stop signal (numbering is taken from the human P-selectin se- 
quence)  in  that  chimera, ssHRP r'-seleclin'~C1 is  the  construct  in 
which the C1 exon has been deleted. 
3H-dopamine  identifies  the  granules  (Fig.  2  B).  As  ex- 
pected, ssHRP  P-selectin therefore appears to be targeted to 
the granules of PC12 cells. This was confirmed by pooling 
the fractions of the granule peak, and centrifuging them to 
equilibrium on a second gradient (2), where they copurify 
with the dopamine (see below). 
To our surprise, in cells expressing ssHRP  Pselectin, we see 
a second large peak toward the top of the Ficoll gradient 
in fractions 2 and 3 in addition to the peak of activity cor- 
responding to the granules. This distribution is similiar to 
that of the SLMV marker p38/synaptophysin on this kind 
of gradient (8, 9). To analyze this material further, we elec- 
troporated  cells  with  pRK34.ssHRP  P-~el~cti", allowed  ex- 
pression to occur, and then centrifuged a postnuclear su- 
pernatant on a 1-16% Ficoll gradient. The peak fractions 
from the top of the velocity gradient were then pooled and 
centrifuged to  equilibrium  on  a  sucrose  gradient  (refer- 
ence 8 and Materials and Methods) designed for the puri- 
fication of synaptic vesicles (Fig. 3).  Fractions were then 
assayed for HRP activity and synaptophysin immunoreac- 
tivity, as determined by Western blotting. These analyses 
showed that the peak of HRP activity colocalized with the 
peak of synaptophysin (or p38) immunoreactivity, suggest- 
ing that ssHRP  P-sdectin is being targeted to the SLMVs of 
PC12 cells, as well as to the DCGs. 
We also examined the distribution of HRP activity after 
ssHRP  P-setectin expression  on a  completely different  frac- 
tionation system that was recently used by Kelly and co- 
workers to examine VAMP/synaptobrevin targeting to the 
SLMVs  of  PC12  cells  (reference  20  and  Materials  and 
Methods).  Cells  were  transfected,  left  for 2  d,  homoge- 
nized, dense material was pelleted, and a supernatant frac- 
tion (S1) was then centrifuged on a glycerol gradient (Ma- 
terials  and  Methods).  Fractions  were  analyzed for HRP 
activity and Synaptophysin immunoreactivity. The results 
(Fig. 4) show that this glycerol gradient protocol also gave 
a  very  good correlation  between  p38  immunoreactivity 
and HRP activity, strongly suggesting that the cytoplasmic 
domain of P-selectin contains information capable of tar- 
geting to SLMVs of PC12 cells. 
Finally, we used immunoisolation of material from the 
glycerol-gradient peak  to confirm that  the  ssHRP Pselectin 
was  in  the  same  membrane  boundary  as  p38/synapto- 
physin  (Fig.  4,  inset).  We  found that  beads  coated with 
anti-p38 could be used to isolate >90% of the enzyme ac- 
tivity, whereas an antibody to a non-neuroendocrine pro- 
tein only pulled out ~2%  of the input activity. Together, 
these three different approaches establish the targeting of 
P-selectin to SLMVs in PC12 cells. 
Targeting to SLMVs of P-selectin has not been reported 
before, but previous analyses have largely been carried out 
using stable cell lines.  We reasoned that the DCGs might 
be more stable than the SLMVs, given the endocytic origin 
of the latter, and that over time in a stably transfected cell 
line,  DCG labeling might become more dominant. To in- 
vestigate this,  we carried out an analysis of the accumula- 
tion of HRP activity in the two different RSOs during 6 d 
after  transfection  with  cDNA  encoding  ssHRP P-selectin. 
Each day after transfection, cells were fractioned either on 
a  1-16% Ficoll gradient to examine the  accumulation of 
HRP activity in DCGs, or on a glycerol gradient to exam- 
ine  HRP activity in  SLMVs. The graph shown in  Fig.  5 
shows that the peak of activity in the DCGs does seem to 
be more stable than that in the SLMVs. 
The experiments described above revealed that we have 
a chimera that is targeted to both RSOs in PC12 cells. This 
provided us with an opportunity to investigate whether sig- 
nals involved in DCG and SLMV targeting are the same 
or different.  To begin  to  analyze what  targeting  signals 
might be present in the chimera, we constructed a series of 
mutations of the cytoplasmic tail  of the P-selectin chimera 
(Fig. 1) loosely based around the two-exon structure (23). 
The first exon within the tail (762-771 of the human P-selec- 
tin sequence), C1, has been shown to be involved in lyso- 
somal targeting in  CHO cells  (16).  We have therefore de- 
leted this C1 domain to reveal its role in RSO targeting in 
PC12 cells.  In addition,  we constructed a  deletion  series 
through the second carboxy-proximal C2 domain. 
To analyze the protein being made by this series of con- 
structs, we electroporated the constructs into PC12 cells, 
allowed expression to occur, and then used a short period 
of metabolic radiolabeling followed by immunoprecipita- 
tion to isolate the newly synthesized material. SDS-PAGE 
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Figure 2.  Distribution of ssHRP  P-selectin on Ficoll velocity gradients at 24-h intervals after transfection, cDNA encoding ssHRP  PseleCtin 
was electroporated into PC12 cells that were then plated out and processed for centrifugation on 1-16% Ficoll gradients at successive 
24-h intervals.  Gradients were fractionated into 0.5-ml fractions, numbering from the top, and HRP activity assayed.  Transfected ceils 
were labeled with 3H-dopamine before fractionation and fractions were counted. (A) Graph showing enzyme activity (OD450) across a 
1-16% Ficoll velocity gradient on I(-E]-), 2(+),  3(-O-), and 4( -~- ) d after transfection. Each fraction was assayed in triplicate, 
and means are shown. (B) A comparison of HRP activity ( ~  ) and 3H-dopamine ( ~  ) labeling 4 d after transfection. Note the cor- 
respondence of the 3H-dopamine peak and the peak of HRP activity in fractions 12-18. Fraction 1 is at the top of the gradient. 
analysis of the immunoprecipitates  demonstrates  that the 
chimeras have the appropriate relative molecular weights 
(data not shown). All of the chimeras were enzymatically 
active. 
To  examine  the  effects  of the  mutations  on  granule 
targeting,  cells  were  transfected  with  cDNAs  encoding 
ssHRP P-selectin and the series of mutant chimeras, left for 4 d 
for expression to rise to levels that allow easy HRP detec- 
tion  during granule  isolation,  labeled  with  3H-dopamine, 
and fractioned on 1-16% Ficoll gradients. Fig. 6 shows the 
profiles  of dopamine  and  HRP  activity  for  all  the  con- 
structs. The pattern of dopamine distribution is extremely 
regular, demonstrating that the fractionation procedure is 
very  reproducible.  The  dopamine  distribution  shows  a 
peak between fractions 12 and 19 representing the DCGs, 
a  pellet  of aggregated material,  and counts at  the  top of 
the  gradient  representing  a  mixture  of  cell-associated 
dopamine that had not been taken up by the granules and 
dopamine released from granules during homogenization. 
The HRP activity on these Ficoll gradients shows a variety 
of different distributions. If the activity in the granule-con- 
taining fractions (as defined by the 3H-dopamine) is exam- 
ined,  it  can  be  seen  that  ssHRP P-selectin, ssHRP P'selectinTs6, 
and  ssHRP P-selectin782 show  significant  peaks  of  activity. 
ssHRP  p-selectin776  and  ssHRP  P-selectinaC1  show  very  minor 
shoulders of activity where the DCGs are. ssHRP P-selectin763 
shows no significant concentration of activity in the DCG 
fractions.  We can purify the  granule  fractions further  by 
pooling and  then  centrifuging  them on a  second sucrose 
gradient. The data for samples containing ssHRP  Pselectin and 
ssHRP p-selectin763 treated in this way are shown in Fig. 7. The 
HRP activity from the DCG peak in cells transfected with 
ssHRP P-selectin remains as a single peak, in the same position 
as that of the dopamine on this second equilibrium gradient. 
The  "granule  peak"  activity  from  cells  transfected  with 
ssHRP P'selectin763, however, runs  as a  single  peak  in lighter 
fractions than the dopamine. The data from ssHRP Pselectin776 
and  ssHRP P'selectinaCl (not shown) reveal small but repro- 
ducible  levels  of activity  in  the  granule-containing  frac- 
tions on the sucrose equilibrium gradients, thus exhibiting 
a partial targeting phenotype. 
These data suggest that the information within the cyto- 
plasmic  tail  required  for  granule  targeting  is  found  be- 
tween amino acids 763 and 782. Disdier et al. have previ- 
ously shown that the granule-targeting information within 
the P-selectin cytoplasmic tail lies after amino acid 763, as 
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Figure 3.  Codistribution of ssHRP P-~lecti" and synaptophysin on a 
0.4-1.2-M  sucrose  gradient.  Cells  were  transfected  with 
pRK34.ssHRP v-s¢lectin,  left for 2 d for HRP activity to accumulate, 
and then fractionated on a  1-16%  Ficoll gradient. HRP activity 
was assayed across the gradient, and the fractions corresponding 
to  the  peak  in  the  light  fractions  (2  and  3)  were  pooled  and 
loaded onto a 0.4-1.2-M sucrose gradient and centrifuged to equi- 
librium. Fractionation was followed by assaying for HRP activity 
(-C]--) and Western blotting for synaptophysin immunoreactivity 
(+).  Immunoreactivity  is  shown  as  phosphodensity  units 
(PDU), as obtained by Phosphor-Imaging. HRP activity (OD450) 
is shown as the mean of triplicate readings. Fraction 1 is at the top 
of the gradient. 
assayed in AtT-20 cells (12). We have established that de- 
letion of the amino acids after 782 have little or no effect 
on granule targeting. Further reduction in length of the C2 
domain or the removal of the C1 domain severely reduce 
the "granule peak." 
We next examined the targeting of the chimeras to the 
SLMVs. We might expect to find that two regions of the 
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Figure 5.  Time course of HRP activity in DCGs and SLMVs af- 
ter transfection. Cells were transfected with pRK34.ssHRP P-senecti" 
and plated out onto 12 9-cm dishes. At daily intervals, one dish 
was fractionated using a 1-16% Ficoll gradient, and one dish was 
fractionated using the glycerol gradient procedure. The HRP ac- 
tivity under the DCG, and SLMV peaks as a percentage of activ- 
ity in the cell homogenate was calculated and is plotted against 
the number of days after transfection. Note that these data  are 
not corrected for organelle recoveries during fractionation. 
cytoplasmic domain are necessary for SLMV targeting, as 
has been predicted  for synaptophysin: an internalization 
signal and a  signal for sorting from the endosome to the 
SLMV (see Fig. 10 A). If this is so, we would predict that 
deleting  one  of  them  (responsible  for  sorting  into  the 
SLMV from the endosome) would leave the protein in the 
endosome. The consequences of deleting the other might 
be to leave the protein accumulating on the plasma mem- 
brane. However, the actual outcome of the removal of an 
internalization signal on events downstream is hard to pre- 
dict,  since  they  depend  on  the  kinetics  of  subsequent 
events as welt as those of internalization.  This is particu- 
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Figure 4.  Codistribution  of ssHRP  P-selectin 
and  synaptophysin  on a  glycerol equilib- 
rium gradient. Cells were transfected with 
pRK34.ssHRP a-selectin, left for 2 d for HRP 
activity to accumulate, homogenized, cen- 
trifuged, and then the S1 fraction was cen- 
trifuged  on  a  5-25%  glycerol  gradient 
(Materials  and  Methods).  Samples  were 
collected  and  assayed  for  HRP  activity 
(~)  and  for synaptophysin  immunore- 
activity ( -dk- ). Fraction 1 is at the top of 
the  gradient.  (Inset)  The  peak  fractions 
(12-16)  from  a  glycerol  gradient  were 
pooled  and  used  as  input  into  an  immu- 
noisolation experiment as described (Ma- 
terials  and  Methods).  The  graph  shows 
HRP activity present in the input (Input), 
as well as that bound to beads coated with 
antisynaptophysin (p38) or a control anti- 
body (C). 
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Figure  6.  Distribution  of chimeras  on 
1-16%  Ficoll  gradients.  Cells  trans- 
fected with  the various chimeras were 
left 4 d for levels of expression  to rise, 
labeled  with  3H-dopamine,  and  then 
fractionated on 1-16% Ficoll gradients. 
3H-Dopamine (-E3--) and HRP activity 
(-I-)  were  assayed  in  each  fraction. 
(A) ssnRPP-setectin;  (B)  ssHRPP-selectin786; 
(C)  ssHRPP'selectin782;  (D)  ssnRPP-selectin776; 
(E) ssHRPP-selectinac1; (F) ssHRP P-selectin763. 
larly important when a  steady-state rather than a  kinetic 
measurement of targeting is being used,  as is the case in 
these experiments. Moreover, experiments aimed at iden- 
tifying a discreet internalization signal within the cytoplas- 
mic tail of P-selectin have not succeeded (39). The other 
possibility  is  that  we  might  find  that  (as  in  the  case  of 
VAMP-II) a single sequence is responsible for SLMV tar- 
geting. There is no obvious sequence  similarity between 
P-selectin and either of the other two proteins that would 
lead to a prediction as to which possibility is correct. 
To analyze the effects of these mutations on SLMV tar- 
geting,  we  used  the  glycerol-gradient  system  described 
above. In our hands, the purity of the SLMVs obtained by 
pooling material from fractions 2 and 3 of the Ficoll gradi- 
ents  and  using  it  in  a  sucrose  gradient  fractionation  is 
lower than those isolated on glycerol gradients.  We have 
therefore determined the targeting efficiency of the exoge- 
nous  ssHRP  P-selectin by  comparing  the  enzyme  activity 
present in the homogenate, S1  fraction, and SLMV peak 
of the glycerol gradient procedure. Following the example 
of Kelly and co-workers (20), we have also monitored the 
targeting  efficiency of an  endogenous  protein  (synapto- 
physin) in each case. This allows for variation in expression 
levels and in efficiency of fractionation to be monitored in 
each transfection/fractionation. Thus, after transfection of 
PC12 cells, expression was allowed to occur, and then sam- 
ples were processed for analysis by glycerol gradient frac- 
tionation.  We  already  had  an  indication  from the  Ficoll 
gradients  shown  in  Fig.  6  that  three  of  the  mutants 
(ssHRP  P-seleclin776,  ssHRP  P-selectinACl,  and  ssHRP  P-selectin763) 
are unlikely to be targeted to SLMVs, since they showed 
no peak in fractions 2 and 3, where synaptophysin peaks. 
HRP activity assays of the fractions showed that all of the 
mutants failed to accumulate in the SLMV fractions (Ta- 
ble 1). No SLMV targeting whatsoever of any of the mu- 
tants  was  seen,  despite  very  reproducible  recoveries  of 
synaptophysin in the SLMV peak, as assayed by quantita- 
tive immunoblotting of peak fractions and homogenates. 
This confirms that the material in fractions 2 and 3 on the 
Ficoll  gradient  contains  a  variety of organelles. We con- 
clude that a sequence encoded at least partly within the C1 
exon and a structure centered on the last four amino acids 
of P-selectin are both required for an itinerary that ends in 
targeting to SLMVs. Presumably, one of these sequences 
leads to inclusion in the budding SLMV, the other causing 
some earlier trafficking event required for delivery to the 
place  where  SLMV  budding  takes place.  We  have not 
yet  determined  whether  further  sequences  are  also  in- 
volved. It is also clear from these data that granule tar- 
geting  and  SLMV  targeting  require  different  sequences 
within P-selectin. 
One trivial explanation for the failure of the mutants to 
reach the SLMVs is that none of them enter the endocytic 
trafficking pathways where SLMV biogenesis is thought to 
occur. If, for example, they did not progress beyond early 
parts of the secretory pathway, then a failure to reach the 
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Figure 7.  Distribution  of ssHRP  P-seleain and ssHRP  r'+cl~ctin763  on 0.5- 
1.5-M sucrose equilibrium gradients.  Cells expressing ssI-tRP  l'-selectin 
(A) and ssHRP P-selectin763 (B) were fractionated on 1-16% Ficoll 
gradients, and the fractions containing DCGs as defined by the 
3H-dopamine peak (13-17) were pooled and centrifuged to equi- 
librium on 0.5-2-M sucrose gradients (Materials  and Methods). 
These gradients were collected, and fractions were assayed for 
3H-dopamine (-iS]-) and HRP activity  (--I-). The Ficoll gradi- 
ents from which the fractions were pooled to produce this figure 
are shown in Fig. 6, A and F. 
SLMV would not be surprising.  The fact that many of the 
mutants are found within DCG suggests that the mutants 
are  capable  of progressing  at  least  to the trans-Golgi.  It 
would  be  surprising  if a  chimera  that  reaches  the  trans- 
Golgi  was  incapable  of  progressing  further,  especially 
since a truncated form of P-selectin is found on the plasma 
membrane  (12).  Moreover,  HRP freely passes  along the 
secretory pathway in a number of chimeras (7, 40). 
Since the key to SLMV biogenesis is thought to be entry 
to the endocytic pathway, we have examined the ability of 
the  chimeras  to  reach  the  cell  surface  and  internalize. 
PC12 cells were transfected so as to express the range of 
chimeras,  and were then  plated  onto coverslips. The live 
cells growing on glass were then incubated for 1 h with an- 
tibodies (either rabbit or mouse) that recognize HRP. The 
rationale  behind  this  procedure  is  that  if  the  chimera 
reaches the cell surface, then antibody binding can occur; 
if internalization  then follows, the antibody will be taken 
into  endosomal  elements.  The  distribution  of  the  anti- 
HRP can then  be discovered by fixing and  then staining 
permeabilized cells with secondary antibodies coupled to a 
fluorophore,  and  using immunofluorescence  microscopy. 
The amount of antibody used in these feeding experiments 
is 1.25 p.g/ml, and is not detectable in untransfected cells. 
The results of such experiments are summarized in Fig. 8. 
These representative examples show that all of the chime- 
ras  reach  the  cell  surface,  ssHRP P-selectin763, the  chimera 
with the shortest cytoplasmic domain, accumulates on the 
surface, and only internalizes to a very limited extent dur- 
ing  the  1-h  incubation  period.  All  the  other  chimeras 
show, in addition to plasma membrane staining, intracellu- 
lar  localization  within  a  variety  of structures.  These  in- 
clude large lysosomal-like punctae,  as well as a  more dif- 
fuse vesicular staining, often in the pericentriolar region of 
the cell.  These results  are  similar to those  obtained  with 
PAM,  where  the  internalization  from  the  plasma  mem- 
brane  to  pericentriolar  endosomes  in  ART-20  cells  has 
been  observed  (32).  The small  round PC12 cells  are  not 
very suitable  material  for  immunofluorescence  analyses, 
however, and in agreement with Kelly and co-workers, we 
have not found it possible  to analyze  these  structures  in 
detail (19), beyond noting that they show similarities with 
both lysosomal (lgp 120) and endosomal (TfnR) markers. 
Apart from ssHRP  P'selectin763, only ssHRP  P'selectin±C1 shows a 
consistently different pattern to the other mutants that are 
internalized. It reveals a more consistent perinuclear stain- 
ing that is reminiscent of the distribution of the TfnR. 
Since  different  anti-HRP  antibodies  show  similar  pat- 
terns,  and  ssHRP  P-selectin763  is  not  driven  in from the  cell 
surface, we believe that the internalization is not driven by 
the  antibody,  but  is  mediated  by signal(s)  present  in  the 
Table L Quantitation  of P-Selectin Targeting  to SLMVs 
HRP activity in  HRP activity in  HRP activity in  HRP activity in  p38 in SLMV 
Chimera  homogenate*  SI fraction*  SLMV peak*  SLMV peak (%)+  peak (%)~ 
ssHRP  P~eJ~¢ti"  267.4 ±  6.6  81.0 ±  4.0  40.44 ±  0.4  15.1  10,1 
ssHRP  P-selectin786  26.4 ±  1.4  0.0 ±  1.0  -0.4  ±  0.12  <1.0  12.4 
ssHRP  p-selectin782  96.2 -+ 2.4  -0.8  ±  0.6  -0.12  --- 0.12  <1.0  15.7 
ssHRP  p-selectin776  209.8 ±  4  3.2 -- 0.2  -0.2  ±  0.16  <  1.0  13.7 
ssHRP  p-selectin763  198.2 ±  3.8  25.8 ±  2.0  -0.12  -+ 0.12  <1.0  14.5 
ssHRP  P-~etecti"~ct  372.4 ±  13.4  99.0 ±  3.2  -0.36  -+ 0.16  <1.0  13.0 
PC 12 cells transfected with cDNA encoding the indicated chimera were left for 2 d, homogenized, and then an S 1 fraction was prepared. This was centrifuged  on a 5-25% glycerol 
gradient as described (Materials and Methods) and fractionated. HRP activity in the homogenate, S I fraction, and across the gradients were determined in triplicate for each sam- 
ple+ Means _+ SD are shown. The SLMV peak was determined to be fractions 12-15 in this representative experiment (see Fig. 5). Homogenate and pooled peak samples were 
Western blotted for synaptophysin immunoreactivity. 
*Total activity in assay was normalised to the starting volume. 
*Percent of homogenate activity found in the SLMV peak. 
~Percent of homogenate immunoreactivity found in the SLMV peak. 
The Journal of Cell Biology, Volume 134, 1996  1236 Figure 8.  Distribution of P-selectin chimeras on the endocytic pathway. Ceils were transfected with the P-selectin chimeras, plated onto 
coverslips,  and subsequently incubated with anti-HRP antibodies for 1 h, as described (Materials and Methods). After fixation and per- 
meabilization,  the anti-HRP was decorated with fluoresceine-tagged  secondary antibodies,  and then examined on an MRC-1000 confocal 
microscope.  (A) ssHRPP'selectin;  (B) ssHRPP-selectin786; (C) ssHRPP-selectin782; (O) ssHRPP'selectin776; (E) ssHRPP-selectinaCl;  (P0 ssHRPP-selectin763. 
cytoplasmic domain  of the  chimeras.  As has  been previ- 
ously found for full-length P-selectin (39), we find no evi- 
dence  for a  simple  internalization  signal  within  the  tail, 
since  we  see  no  accumulation  on  the  cell  surface  other 
than when most of the  cytoplasmic domain has  been  re- 
moved. We cannot determine whether the route taken af- 
ter internalization  is affected by antibody binding.  These 
data, though qualititative,  suggest that chimeric molecules 
that are not sorted in the TGN into granules traffic to the cell 
surface and are then, with one exception (ssHRPP'selectin763), 
capable of internalizing into at least some endosomal com- 
partment(s), possibly including that subcompartment from 
which SLMV biogenesis can occur. 
From the glycerol gradient  data,  a  sequence within  C1 
and another  centered  on the last four amino acids of the 
cytoplasmic domain are both necessary for SLMV target- 
ing. Models for SLMV biogenesis discussed above suggest 
that  these  two  sequences  might be  involved  in  different 
sorting steps. If this is so, then we might see differences be- 
tween the itinerary of the two mutants after reaching the 
cell  surface.  The  low  resolution  of immunofluorescence 
microscopy in PC12 cells  means  that  any differences  be- 
tween  ssHRP  P-selectin7s6  and  ssHRP  e'selectin±cl  revealed  by 
the  antibody-feeding  experiments  are  not  clear  cut,  al- 
though it should be noted that neither chimera shows any 
evidence of accumulation on the plasma membrane. When 
the  biochemical  data  in Table  I  are  examined,  however, 
there  is  some  indirect  evidence  suggesting  that  the  two 
chimeras  are differentially  targeted.  If the fraction of ac- 
tivity in the S1 fraction is compared to that in the homoge- 
nate  (Table  I),  it  can  be  seen  that  ssHRP  p-selectin786 and 
ssHRP  P'se|ectinAC1 show a  different  distribution  of activity. 
Despite both mutants showing strong activity in the homo- 
genate, only ssHRP  P'selectioAC1 shows activity in the S1 frac- 
tion.  This  presumably  reflects  differential  targeting  and, 
together  with  the  fluorescence,  suggests  that  these  two 
mutants that fail to reach the SLMVs may have different 
destinations after reaching the cell surface. 
These results  suggested that the synaptophysin-derived 
model of SLMV targeting was likely to be applicable  to 
P-selectin.  The  strongest  prediction  of this  model  is  that 
we should be able to find a sequence that is responsible for 
sorting from the TfnR-rich endosome to the SLMV. To in- 
vestigate more directly whether deletion of either of these 
two sequences leaves the chimera in the TfnR-rich endo- 
some,  we  compared  the  distribution  of  ssHRP  P-~e~ectinTs6 
and  ssHRP  P~etecti"acl with  that  of  a  chimera  comprising 
HRP and the signal anchor and cytoplasmic domain of the 
TfnR, which is targeted to the endosome (40).  Of the two 
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Figure 9.  Distribution  of ssHRP P-selectin786, ssHRP P-seleetinaC1, and 
TfnR-HRP activity on a Ficoll velocity gradient.  9-cm dishes 
of  PC12  cells  were  transfected  with  cDNA  encoding  either 
ssHRP  -P'~e~tinT~6 (~),  ssHRPP'~leamacl(  -~- ), or TflW,-HRP(-O- ), 
left for 4 d for HRP activity  to accumulate, and postnuclear su- 
pernatants  were  fractionated  on  a  1-16%  velocity  gradient. 
HRP activity (OD450) was assayed in triplicate in each fraction, 
and the mean is shown. Note the similarity  in distribution of en- 
zyme activity from ssHRP P'selectinacl and TfnR-HRP. 
Norcott el al. P-Selectin in PCI2 Cells  1237 mutants,  ssHRP  PselectinaC1 shows  a  distribution  similar to 
that of the TfnR-HRP on the  1-16%  Ficoll gradient sys- 
tem (Fig. 9). The other mutant does not show any signifi- 
cant colocalization with the TfnR-HRP. 
Discussion 
In  this  paper,  we demonstrate  that  ssHRP  r'~selectin is tar- 
geted to both RSOs of PC12 cells after a transient trans- 
fection.  Previous investigations  of the  sequences  within 
P-selectin that are responsible for its itinerary have shown 
that the cytoplasmic domain is both necessary and suffi- 
cient for RSO targeting (12, 26). We are therefore confi- 
dent that ssHRP Pselectin distribution reflects that of the full 
protein.  Hitherto,  P-selectin has been  reported  as being 
targeted to the DCGs only (12,  16,  26).  The reasons for 
this difference may be twofold: first, we began these stud- 
ies  using  a  fractionation  scheme  that  is  deliberately de- 
signed to show both DCGs and SLMVs on one gradient, 
and secondly, we have used a transient expression system. 
Thus,  the  velocity gradients  revealed  that  ssHRP Pselectin 
had  a  bimodal  distribution  reminiscent  of VAMP  II or 
synaptobrevin, which is found in both the RSOs (5, 36). 
Subsequent further purification of the SLMVs by two dif- 
ferent  gradient  systems,  one  adapted  from  a  rat  brain 
small synaptic vesicle purification procedure  (8) and one 
introduced by Kelly and co-workers (20), as well as immu- 
noisolation, was used to confirm that the P-selectin was to 
be found in SLMVs. The physiological significance of this 
finding is not clear, but the differential targeting that we 
have revealed by mutagenesis suggests that it is not simply 
that any exogenous RSO membrane protein expressed in 
PC12 cells will end up in both RSOs as a consequence of 
possessing a general RSO-targeting signal. Another possi- 
ble implication of our data is that a careful search of he- 
matopoietic cells might reveal the presence of SLMV-Iike 
structures. 
We suspect that the use of a transient expression system 
may have  increased  the  fraction  of ssHRP  Psdectin in  the 
SLMVs relative to the DCGs. Close inspection of the pub- 
lished  data  from expression  in  PC12  cells  suggests  that 
others may also have found a small fraction of this protein 
in the SLMVs when stable lines have been analyzed (16). 
Our data shown in Fig. 5 imply that in a stable line, DCGs 
might  well  become  the  dominant  pool  of  this  protein 
within  RSOs.  It is  not clear what causes the  stability of 
SLMVs to be lower than that of DCGs, but it may reflect a 
greater flow of membrane protein through the SLMV than 
through the DCG, resulting from a higher basal level of fu- 
sion of the former with the plasma membrane. This might 
reflect SLMV origins in the endosome. Moreover, the vul- 
nerability to degradation of a protein cycling through the 
endosome might be exacerbated in the case of P-selectin 
by the presence of a lysosomal targeting signal (16). 
Sorting  of newly  synthesised  membrane  proteins  into 
DCGs probably occurs in the TGN. Published experiments 
(12) show that the granule targeting signal for P-selectin is lo- 
cated within the last 27 amino acids of the cytoplasmic do- 
main.  We  have confirmed  this  observation,  and  suggest 
that the signal(s) location is between amino acids 763 and 
782.  The fact that we generate mutants  (ssHRP  P-selectin776, 
ssHRP  vselectinaCl) that  alter  the  efficiency  of  targeting 
rather than completely ablate it may be caused by the small 
number of relatively large alterations that we have made 
in the chimeras; we may be significantly affecting the con- 
text in which a DCG-targeting signal is operating. Alterna- 
tively, the data may suggest the presence of more than one 
targeting signal, which could act in concert to cause effi- 
cient targeting. These issues can be resolved by a more de- 
tailed mutagenic examination. 
One important finding is that the sequences responsible 
for targeting to the two RSOs are different. Although it is 
clear that some RSO membrane proteins are differentially 
targeted to one or other of the two RSOs, and that there- 
fore signals for both DCGs and SLMVs must exist, it has 
not before been shown that a protein with a biorganellar 
location can have signals for both.  The only other pub- 
lished analysis of trafficking signals in a membrane protein 
that is found in both RSOs is VAMP-II. This protein turns 
out  to  have  a  single  signal  for targeting  to  the  SLMV, 
which is thought to act by allowing VAMP-II to interact 
with an SLMV protein that does carry appropriate signals. 
In principle, this could extend to granule targeting as well, 
but granule targeting has not yet been investigated for this 
molecule. 
One of the unresolved issues with respect to RSO tar- 
geting is the relationship between the pools of SLMV and 
DCG protein.  In these experiments, we have found  that 
we can make chimeras that are targeted to only one of the 
two RSOs. Those mutants that do reach the granules, but 
not the SLMVs, show no increase in DCG targeting rela- 
tive to the chimera with the wild-type P-selectin sequence. 
This is in line with the results of the mutagenesis, which 
suggests that separate targeting signals exist, and therefore 
relatively independent  targeting to the two RSOs should 
occur. This result is also consistent with current views of 
membrane  trafficking,  where  granule  biogenesis  in  the 
TGN takes place before SLMV budding in the endosome 
during  the  itinerary  of a  newly  synthesised  RSO  mem- 
brane protein. This explanation also implies that there is 
no  significant  trafficking of this  particular  RSO  protein 
back to the DCG from the endosome in PC12 cells. This 
conclusion  is  at  variance  from that  of Koedam  and  co- 
workers  (42),  who  concluded  from  an  immunofluores- 
cence study that recycling to granules in AtT-20 cells could 
occur. It is not clear whether this is cell type specific or re- 
lates to the different techniques, but we do not see any ev- 
idence of recycling to granules in the antibody-feeding ex- 
periments  described  above, although  PC12  cells are not 
such a  good system for light-level microscopy as ART-20 
cells. Recycling to the granule can occur in some cells, in- 
cluding chromaffin cells (21). It is also possible that the ly- 
sosomal-targeting signal present in P-selectin, which prob- 
ably relates to the physiological role of this protein (16), 
operates to prevent recycling back to the granule, and that 
another RSO protein that lacks such a signal will behave 
differently. If subsequent mutagenesis enables us to gener- 
ate a mutant chimera that is only targeted to the SLMVs, 
but not the DCGs, it will be of interest to see if SLMV tar- 
geting is increased relative to wild-type. 
It has been argued above that there will be two targeting 
signal-dependent steps of traffic involved in the transport 
of proteins  to SLMVs:  a  facilitating signal  to  allow effi- 
cient  internalization  to  the  endosome  from  the  plasma 
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Figure 10.  Models for trafficking of P-selectin in PC12 cells. This 
diagram illustrates  the trafficking of P-Selectin from the Golgi 
(G)  to the SLMV (O)  via endosomal elements  (El  and  E2), 
where E1 is the TfnR-rich endosome, and E2 is some other sub- 
compartment.  Note that this  diagram is simplified  by ignoring 
that portion of the P-selectin  targeted to DCGs.  (A) A  model 
where  trafficking to the  cell  surface  (1)  is  followed by signal- 
dependent internalization to E1 (2). A signal-dependent step (3) 
is then required for sorting into the SLMV. In this model, the se- 
quence DPSP is required for 2, and the C1 domain is required for 
step 3.  (B) A  model where traffic to the cell surface (1)  is fol- 
lowed by internalization  (2),  which may be signal  dependent to 
TfnR-rich endosomes (El). A signal-dependent step (3) causing 
sorting into a second endosomal compartment (E2) is followed 
by a second signal-dependent sorting into the SLMV (4). In this 
model, the C1 domain is required for step 3, and the tetrapeptide 
sequence DPSP is required for step 4. Filled arrows refer to the 
signal-dependent steps discussed  above and in the main text. 
membrane plus an SLMV-targeting signal that causes sort- 
ing into the the SLMV from the endosome (Fig. 10 A). On 
the other hand, VAMP II mutagenesis and expression re- 
vealed the presence of only one targeting signal (20). We 
interpret  the results of our mutagenesis as consistent with 
the presence of two signals, both of which are required for 
arrival in the SLMV. We have no direct evidence for this, 
but the different intracellular locations of ssHRP P'selectin786 
and  ssHRP l'-selectinACl strongly suggests  that  two different 
signals are involved. Moreover, almost all of ssHRP P-selectinAC1 
colocalizes with  the  TfnR-HRP chimera  on Ficoll  gradi- 
ents, and antibody-feeding experiments show that this mu- 
tant can reach the cell surface and is then internalized to a 
perinuclear  endosomal  localization.  If the  SLMV  arises 
from the TfnR-rich endosome, then this  implies  that the 
SLMV-specific targeting sequence has been removed. This 
is very apt, since it has been shown that in cells that lack 
the SLMV-specific targeting machinery, synaptophysin is 
found to colocalize with the TfnR (but see reference 28 for 
a caveat to this view). 
If the  C1 domain  contains the  SLMV-targeting  signal, 
then the DPSP motif might be expected  to be the signal 
for internalization  from the plasma membrane.  However, 
DPSP shows no obvious resemblance  to known internal- 
ization signals (44), and its removal does not cause an ac- 
cumulation  on  the  plasma  membrane,  as  would  be  re- 
vealed by the  anti-HRP feeding experiments  (Fig.  8).  In 
addition, a recent analysis of endocytosis of P-selectin mu- 
tants (39) shows that removal of DPSP does not strikingly 
reduce  internalization  rates.  In fact,  our  feeding  experi- 
ments show results similar to those found by McEver and 
co-workers (39), who failed to identify a  single simple in- 
ternalization signal in P-selectin. 
If the tetrapeptide DPSP is not an internalization signal, 
then  an  alternative  explanation  of our  data  may be  re- 
quired. The data may be explained by the C1 domain be- 
ing important in targeting P-selectin away from the TfnR- 
positive membranes to another distribution within the en- 
dosomal system (Fig.  10 B),  rather  than  from the  TfnR- 
rich compartment to the SLMV. Given the role of the C1 
domain in lysosomal targeting (16), i.e., in trafficking out 
of the  early  TfnR-positive  endosome,  we  speculate  that 
the C1 domain may cause targeting to a second endosomal 
compartment  from  which  the  SLMVs  form.  The  DPSP 
motif would then be responsible for the final sorting away 
from this endosome to the SLMV (Fig. 10 B). 
One of the major problems with distinguishing between 
these  different hypotheses is that endocytic trafficking in 
PC12  cells  is  poorly  understood  compared  with  the  de- 
tailed  picture  that  is  emerging  from  extensive  work  in 
other systems, and it is complicated by the presence both 
of RSOs and of the phenomenon of neuronal cell polarity. 
We are confident, however, that the ssHRP P-selectin chime- 
ras will provide a way to unravel the complex web of post- 
Golgi  traffic  that  is  the  itinerary  of an  RSO  membrane 
protein. 
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